SHPRH and nasopharyngeal carcinoma: UBC13, HLTF, and SHPRH in the TS pathway, RAD51 and BRCA1 in the HR pathway, and FANCD2 in the FA pathway are highly expressed in cisplatin-resistant nasopharyngeal carcinoma (NPC) cells.